Literature DB >> 21203772

Management of pulmonary hypertension in Down syndrome.

Amy Hawkins1, Simon Langton-Hewer, John Henderson, Robert Michael Tulloh.   

Abstract

UNLABELLED: Children with Down syndrome (DS) are at greater risk of pulmonary arterial hypertension (PAH) than the general population, partly due to upper airway obstruction and congenital heart disease. We wished to review our management of PAH and suggest a protocol for the systematic management of these children. Children with DS and PAH were included as referred for assessment from March 2005 to May 2010. Twenty-five patients (13 boys) met inclusion criteria. The median age was 385 days (range, 106 to 5,734); mean tricuspid regurgitation jet was 3.5 (range, 2.7-4.8) m/s. At cardiac catheterisation, mean pulmonary artery mean pressure was 26 mmHg (range, 12 to 46), and mean pulmonary vascular resistance (PVR) was 4.14 U.m² (range, 1.20 to 12.43) at baseline. PVR fell to a mean of 2.68 U.m² (range, 0.38 to 10.69) with 20 ppm inhaled nitric oxide and 100% oxygen. Respiratory assessment included polysomnography (18), bronchoscopy (16), showing malacia (eight), adenotonsillar hypertrophy (eight) and floppy aryepiglottic folds (four). One lung biopsy showed plexogenic arteriopathy, and one was diagnosed with tracheo-oesophageal fistula.
CONCLUSION: In order to manage this complex group of patients, a combined cardiological, respiratory and surgical approach was required. A protocol with cardiac catheterisation, blood tests and respiratory assessment is suggested for the management of pulmonary hypertension in these children.

Entities:  

Mesh:

Year:  2011        PMID: 21203772     DOI: 10.1007/s00431-010-1378-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

Review 1.  Down's syndrome.

Authors:  Nancy J Roizen; David Patterson
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

2.  Population-based study of congenital heart defects in Down syndrome.

Authors:  S B Freeman; L F Taft; K J Dooley; K Allran; S L Sherman; T J Hassold; M J Khoury; D M Saker
Journal:  Am J Med Genet       Date:  1998-11-16

3.  Chronic upper airway obstruction and pulmonary hypertension in Down's syndrome.

Authors:  T W Rowland; L G Nordstrom; M S Bean; H Burkhardt
Journal:  Am J Dis Child       Date:  1981-11

4.  Aryepiglottoplasty for laryngomalacia: the Alder Hey experience.

Authors:  J E Martin; K E Howarth; I Khodaei; A Karkanevatos; R W Clarke
Journal:  J Laryngol Otol       Date:  2005-12       Impact factor: 1.469

5.  Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life?

Authors:  Munetaka Masuda; Hideaki Kado; Yoshihisa Tanoue; Koji Fukae; Tatsushi Onzuka; Yuichiro Shiokawa; Toshihiko Shirota; Hisataka Yasui
Journal:  Eur J Cardiothorac Surg       Date:  2004-12-30       Impact factor: 4.191

6.  Development of valve dysfunction in adolescents and young adults with Down syndrome and no known congenital heart disease.

Authors:  R L Geggel; J E O'Brien; M Feingold
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

7.  Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.

Authors:  M Rabinovitch; J F Keane; W I Norwood; A R Castaneda; L Reid
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

8.  Diagnosis and therapy for airway obstruction in children with Down syndrome.

Authors:  Ron B Mitchell; Ellen Call; James Kelly
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-06

9.  Comparison of hemodynamic data before and after corrective surgery for Down's syndrome and ventricular septal defect.

Authors:  T Kawai; Y Wada; T Enmoto; K Nishiyama; K Kitaura; S Sato; T Oka
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

10.  The clinical course of cardiac disease in Down's syndrome.

Authors:  R D Greenwood; A S Nadas
Journal:  Pediatrics       Date:  1976-12       Impact factor: 7.124

View more
  11 in total

1.  Refractory pulmonary hypertension following extremely preterm birth: paradoxical improvement in oxygenation after atrial septostomy.

Authors:  Hiroki Saitsu; Osuke Iwata; Junichiro Okada; Akiko Hirose; Hiroshi Kanda; Toyojiro Matsuishi; Kenji Suda; Yasuki Maeno
Journal:  Eur J Pediatr       Date:  2013-08-03       Impact factor: 3.183

Review 2.  Evaluation and Management of Children with Obstructive Sleep Apnea Syndrome.

Authors:  Anna C Bitners; Raanan Arens
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

3.  Down syndrome masked by Marfan syndrome in a neonate.

Authors:  Katie Eayrs; Naveen Shettihalli; Satish Adwani
Journal:  BMJ Case Rep       Date:  2013-03-11

Review 4.  The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series).

Authors:  Steven H Abman; Christopher Baker; Jason Gien; Peter Mourani; Csaba Galambos
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

5.  Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension: results from a long-term, single center, real-world follow-up.

Authors:  Silvia Favilli; Gaia Spaziani; Piercarlo Ballo; Veronica Fibbi; Gennaro Santoro; Enrico Chiappa; Chiara Arcangeli
Journal:  Intern Emerg Med       Date:  2015-01-09       Impact factor: 3.397

Review 6.  Evolving management of pediatric pulmonary arterial hypertension: impact of phosphodiesterase inhibitors.

Authors:  Andrew James Wardle; Robert M R Tulloh
Journal:  Pediatr Cardiol       Date:  2012-12-19       Impact factor: 1.655

7.  Congenital Heart Defect and Pulmonary Hypertension in Children With Down Syndrome: Clinical Profile Over Two Decades.

Authors:  Abdullah N Alhuzaimi; Najoud M Alotaibi; Ghadah I Alsuhaibani; Reem K Alanazi; Mohamad-Hani Temsah
Journal:  Cureus       Date:  2021-02-07

Review 8.  New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease.

Authors:  Leslye Venegas-Zamora; Francisco Bravo-Acuña; Francisco Sigcho; Wileidy Gomez; José Bustamante-Salazar; Zully Pedrozo; Valentina Parra
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599

9.  Longitudinal assessment of cardiac function in infants with Down's syndrome using novel echocardiography techniques - project protocol.

Authors:  Aisling Smith; Eleanor Molloy; Jan Miletin; Anna Curley; Joanne Balfe; Orla Franklin; Afif El-Khuffash
Journal:  HRB Open Res       Date:  2020-10-21

10.  Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.

Authors:  Maurice Beghetti; Andrzej Rudzinski; Min Zhang
Journal:  BMC Cardiovasc Disord       Date:  2017-07-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.